BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 18756941)

  • 1. Patient comprehension and attitudes toward maintenance chemotherapy for lung cancer.
    Gerber DE; Hamann HA; Rasco DW; Woodruff S; Lee SJ
    Patient Educ Couns; 2012 Oct; 89(1):102-8. PubMed ID: 22632736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the role of maintenance therapy in the treatment of non-small cell lung cancer?
    Jiang Y; Owonikoko TK; Ramalingam SS; Khuri FR; Belani CP
    Ther Adv Med Oncol; 2010 Jul; 2(4):229-35. PubMed ID: 21789136
    [No Abstract]   [Full Text] [Related]  

  • 3. Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer.
    Wilson C; Danson SJ
    Lung Cancer (Auckl); 2010; 1():37-51. PubMed ID: 28210105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib in non-small-cell lung cancer-an old lesson new re-visited.
    Dempke WC
    Transl Lung Cancer Res; 2013 Dec; 2(6):435-8. PubMed ID: 25806264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib.
    Chen F; Luo X; Zhang J; Lu Y; Luo R
    Med Oncol; 2010 Sep; 27(3):950-7. PubMed ID: 19830603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy].
    Sun Y; Wu YL; Li LY; Liao ML; Jiang GL; Kim ES; Douillard JY; Milenkova T
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):377-80. PubMed ID: 21875470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of efficacy and safety of ZD1839 as monotherapy in Chinese patients with advanced non-small cell lung cancer].
    Wang MZ; Li LY; Wang SL; Zhang XT; Zhong W; Zhang L; Li JR
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):291-5. PubMed ID: 18843952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].
    Huang H; Zhang Y; Zhao HY; Wang ZQ; Xu F; Xu GC; Zhang L; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):148-51. PubMed ID: 19538895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].
    Wu C; Li LY; Wang MZ; Zhang L; Zhang XT; Zhong W; Wang SL; Wang HZ
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):943-5. PubMed ID: 18478938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of gefitinib on advanced non-small cell lung cancer of bilateral diffuse or unilateral giant mass type].
    Wen ZS; Chen XQ; Wu HY; Wei WD; Rong TH
    Ai Zheng; 2007 Apr; 26(4):415-7. PubMed ID: 17430664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of gefitinib in maintenance therapy for patients with advanced non-small cell lung cancer].
    Wang MZ; Zhong W; Zhang L; Li LY; Wang SL; Li JR; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):221-4. PubMed ID: 18756941
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.